Primary |
Drug Use For Unknown Indication |
15.4% |
Systemic Lupus Erythematosus |
15.4% |
Hypertension |
13.5% |
Pain |
5.8% |
Product Used For Unknown Indication |
5.8% |
Asthma |
3.8% |
Gastritis Prophylaxis |
3.8% |
Hypercholesterolaemia |
3.8% |
Induced Abortion |
3.8% |
Inferior Venacaval Thrombosis |
3.8% |
Nephrotic Syndrome |
3.8% |
Nephrotic Syndrome With Lesion Of Membranous Glomerulonephritis |
3.8% |
Vena Cava Thrombosis |
3.8% |
Atrial Fibrillation |
1.9% |
Constipation |
1.9% |
Hyperlipidaemia |
1.9% |
Hyperuricaemia |
1.9% |
Oedema Peripheral |
1.9% |
Paradoxical Drug Reaction |
1.9% |
Pulmonary Embolism |
1.9% |
|
Ventricular Septal Defect |
18.2% |
Death |
9.1% |
Dermatitis Herpetiformis |
9.1% |
Hyperkalaemia |
9.1% |
Hyponatraemia |
9.1% |
Hyposmia |
9.1% |
Pulmonary Congestion |
9.1% |
Renal Failure Acute |
9.1% |
Upper Airway Obstruction |
9.1% |
Vomiting |
9.1% |
|
Secondary |
Drug Use For Unknown Indication |
29.4% |
Hypertension |
17.8% |
Spinal Osteoarthritis |
5.8% |
Tachyarrhythmia |
5.1% |
Product Used For Unknown Indication |
4.4% |
Atrial Fibrillation |
4.1% |
Chronic Obstructive Pulmonary Disease |
3.8% |
Rheumatoid Arthritis |
3.1% |
Pain |
2.8% |
Coronary Artery Disease |
2.6% |
Osteoporosis |
2.6% |
Thrombosis Prophylaxis |
2.6% |
Hyperlipidaemia |
2.5% |
Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
Pneumonia Aspiration |
2.0% |
Cough |
1.8% |
Hypercholesterolaemia |
1.8% |
Hypokalaemia |
1.8% |
Sedation |
1.8% |
Polyuria |
1.7% |
|
Transaminases Increased |
14.3% |
Suicide Attempt |
9.1% |
Rhabdomyolysis |
7.8% |
Toxic Epidermal Necrolysis |
7.8% |
Tubulointerstitial Nephritis |
7.8% |
Urine Colour Abnormal |
6.5% |
Chest Pain |
5.2% |
Hyponatraemia |
5.2% |
Hypotension |
5.2% |
Renal Failure Acute |
3.9% |
Stevens-johnson Syndrome |
3.9% |
Ventricular Septal Defect |
3.9% |
Gastritis |
2.6% |
Lung Infiltration |
2.6% |
Swollen Tongue |
2.6% |
Syncope |
2.6% |
Thinking Abnormal |
2.6% |
Umbilical Hernia |
2.6% |
Visual Disturbance |
2.6% |
Accidental Exposure To Product |
1.3% |
|
Concomitant |
Drug Use For Unknown Indication |
21.3% |
Hypertension |
20.6% |
Product Used For Unknown Indication |
17.3% |
Prophylaxis |
5.2% |
Diabetes Mellitus |
3.2% |
Rheumatoid Arthritis |
3.1% |
Atrial Fibrillation |
3.0% |
Chronic Obstructive Pulmonary Disease |
2.9% |
Non-small Cell Lung Cancer |
2.8% |
Coronary Artery Disease |
2.5% |
Cardiac Failure |
2.2% |
Parkinson's Disease |
2.2% |
Prophylaxis Against Transplant Rejection |
2.2% |
Immunosuppression |
2.0% |
Breast Cancer |
1.7% |
Pain |
1.7% |
Prostate Cancer |
1.7% |
Depression |
1.6% |
Myocardial Infarction |
1.5% |
Thrombosis Prophylaxis |
1.4% |
|
Vomiting |
8.7% |
Hypertensive Crisis |
6.5% |
Pneumonia |
6.5% |
Pyrexia |
6.5% |
General Physical Health Deterioration |
6.0% |
Pulmonary Embolism |
6.0% |
Renal Failure |
6.0% |
Thrombocytopenia |
6.0% |
Myocardial Infarction |
5.4% |
Weight Decreased |
5.4% |
Transaminases Increased |
4.9% |
Urinary Tract Infection |
4.9% |
Death |
3.8% |
Pain |
3.8% |
Necrosis |
3.3% |
Pleural Effusion |
3.3% |
Renal Failure Acute |
3.3% |
Sepsis |
3.3% |
Somnolence |
3.3% |
Tachycardia |
3.3% |
|
Interacting |
Hypertension |
25.0% |
Tachyarrhythmia |
17.6% |
Rheumatoid Arthritis |
11.8% |
Drug Use For Unknown Indication |
5.9% |
Hyperlipidaemia |
5.9% |
Immunosuppressant Drug Therapy |
5.9% |
Iron Deficiency |
5.9% |
Osteoporosis |
5.9% |
Prophylaxis Against Gastrointestinal Ulcer |
5.9% |
Restlessness |
5.9% |
Lung Transplant |
2.9% |
Pneumocystis Jiroveci Pneumonia |
1.5% |
|
Transaminases Increased |
57.1% |
Drug Interaction |
14.3% |
Hypotension |
14.3% |
Reticulocytopenia |
14.3% |
|